TYR and melanoma: Hence, these results suggest that EDEM2 reduces ST-TYR levels in melanoma cells by targeting the substrate to the ubiquitin–proteasome degradation, and this event is dependent on the N-glycan mannose trimming in A375 melanoma cells.